| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | nuclear RNA export factor complex | 6.72e-05 | 7 | 38 | 2 | GO:0042272 | |
| GeneOntologyCellularComponent | transcription export complex | 2.10e-04 | 12 | 38 | 2 | GO:0000346 | |
| HumanPheno | Increased corneal diameter | 2.41e-05 | 168 | 12 | 5 | HP:0007660 | |
| HumanPheno | Decreased corneal thickness | 2.63e-05 | 171 | 12 | 5 | HP:0100689 | |
| HumanPheno | Abnormal corneal thickness | 2.94e-05 | 175 | 12 | 5 | HP:0011486 | |
| HumanPheno | Hypoplasia of the brainstem | 3.87e-05 | 89 | 12 | 4 | HP:0002365 | |
| HumanPheno | Aplasia/Hypoplasia of the brainstem | 4.05e-05 | 90 | 12 | 4 | HP:0007362 | |
| Domain | Leu-rich_rpt | 8.89e-07 | 271 | 37 | 7 | IPR001611 | |
| Domain | LRR | 2.54e-06 | 201 | 37 | 6 | PS51450 | |
| Domain | - | 2.74e-06 | 321 | 37 | 7 | 3.80.10.10 | |
| Domain | L_dom-like | 3.16e-06 | 328 | 37 | 7 | IPR032675 | |
| Domain | LRR_1 | 4.16e-06 | 219 | 37 | 6 | PF00560 | |
| Domain | LRR_8 | 2.09e-05 | 171 | 37 | 5 | PF13855 | |
| Domain | Tap_RNA_bd | 2.29e-05 | 4 | 37 | 2 | PD043466 | |
| Domain | Tap_RNA-bd | 2.29e-05 | 4 | 37 | 2 | IPR015245 | |
| Domain | Tap-RNA_bind | 2.29e-05 | 4 | 37 | 2 | PF09162 | |
| Domain | Leu-rich_rpt_typical-subtyp | 2.46e-05 | 177 | 37 | 5 | IPR003591 | |
| Domain | LRR_TYP | 2.46e-05 | 177 | 37 | 5 | SM00369 | |
| Domain | LRRNT | 4.12e-05 | 98 | 37 | 4 | IPR000372 | |
| Domain | LRRNT | 4.12e-05 | 98 | 37 | 4 | SM00013 | |
| Domain | PH-BEACH_dom | 1.06e-04 | 8 | 37 | 2 | IPR023362 | |
| Domain | NTF2 | 1.06e-04 | 8 | 37 | 2 | PF02136 | |
| Domain | PH_BEACH | 1.06e-04 | 8 | 37 | 2 | PS51783 | |
| Domain | - | 1.06e-04 | 8 | 37 | 2 | 2.30.29.40 | |
| Domain | Nuclear_transport_factor_2_euk | 1.06e-04 | 8 | 37 | 2 | IPR018222 | |
| Domain | Beach | 1.36e-04 | 9 | 37 | 2 | PF02138 | |
| Domain | - | 1.36e-04 | 9 | 37 | 2 | 1.10.1540.10 | |
| Domain | NTF2 | 1.36e-04 | 9 | 37 | 2 | IPR002075 | |
| Domain | BEACH_dom | 1.36e-04 | 9 | 37 | 2 | IPR000409 | |
| Domain | Beach | 1.36e-04 | 9 | 37 | 2 | SM01026 | |
| Domain | NTF2_DOMAIN | 1.36e-04 | 9 | 37 | 2 | PS50177 | |
| Domain | BEACH | 1.36e-04 | 9 | 37 | 2 | PS50197 | |
| Domain | LRRNT | 1.57e-04 | 53 | 37 | 3 | PF01462 | |
| Domain | - | 2.94e-04 | 13 | 37 | 2 | 3.10.450.50 | |
| Domain | NTF2-like_dom | 3.95e-04 | 15 | 37 | 2 | IPR032710 | |
| Domain | Cys-rich_flank_reg_C | 7.47e-04 | 90 | 37 | 3 | IPR000483 | |
| Domain | LRRCT | 7.47e-04 | 90 | 37 | 3 | SM00082 | |
| Domain | WD40 | 1.67e-03 | 259 | 37 | 4 | PF00400 | |
| Domain | WD40 | 1.89e-03 | 268 | 37 | 4 | SM00320 | |
| Domain | WD40_repeat | 1.99e-03 | 272 | 37 | 4 | IPR001680 | |
| Domain | WD_REPEATS_1 | 2.16e-03 | 278 | 37 | 4 | PS00678 | |
| Domain | WD_REPEATS_2 | 2.18e-03 | 279 | 37 | 4 | PS50082 | |
| Domain | WD_REPEATS_REGION | 2.18e-03 | 279 | 37 | 4 | PS50294 | |
| Domain | WD40_repeat_dom | 2.74e-03 | 297 | 37 | 4 | IPR017986 | |
| Domain | - | 4.12e-03 | 333 | 37 | 4 | 2.130.10.10 | |
| Domain | WD40_repeat_CS | 4.15e-03 | 164 | 37 | 3 | IPR019775 | |
| Domain | WD40/YVTN_repeat-like_dom | 4.21e-03 | 335 | 37 | 4 | IPR015943 | |
| Pubmed | FBXW10 promotes hepatocarcinogenesis in male patients and mice. | 1.16e-06 | 2 | 38 | 2 | 31400758 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 37450367 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 12694398 | ||
| Pubmed | Agenesis of the corpus callosum in Nogo receptor deficient mice. | 3.48e-06 | 3 | 38 | 2 | 27339102 | |
| Pubmed | The nogo receptor family restricts synapse number in the developing hippocampus. | 3.48e-06 | 3 | 38 | 2 | 22325200 | |
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 29024660 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 23675524 | ||
| Pubmed | 7.72e-06 | 1285 | 38 | 9 | 35914814 | ||
| Pubmed | 1.16e-05 | 5 | 38 | 2 | 17978099 | ||
| Pubmed | 1.16e-05 | 5 | 38 | 2 | 37277019 | ||
| Pubmed | Adaptor Aly and co-adaptor Thoc5 function in the Tap-p15-mediated nuclear export of HSP70 mRNA. | 1.16e-05 | 5 | 38 | 2 | 19165146 | |
| Pubmed | Structure and axon outgrowth inhibitor binding of the Nogo-66 receptor and related proteins. | 1.16e-05 | 5 | 38 | 2 | 12839991 | |
| Pubmed | A genome-wide association study of carotid atherosclerosis in HIV-infected men. | 2.43e-05 | 7 | 38 | 2 | 20009918 | |
| Pubmed | Chtop is a component of the dynamic TREX mRNA export complex. | 2.43e-05 | 7 | 38 | 2 | 23299939 | |
| Pubmed | 2.43e-05 | 7 | 38 | 2 | 26335717 | ||
| Pubmed | LGI1 is a Nogo receptor 1 ligand that antagonizes myelin-based growth inhibition. | 2.43e-05 | 7 | 38 | 2 | 20463223 | |
| Pubmed | NgR1 and NgR3 are receptors for chondroitin sulfate proteoglycans. | 3.24e-05 | 8 | 38 | 2 | 22406547 | |
| Pubmed | 3.24e-05 | 8 | 38 | 2 | 14664809 | ||
| Pubmed | 4.16e-05 | 9 | 38 | 2 | 9182797 | ||
| Pubmed | 4.16e-05 | 9 | 38 | 2 | 11566096 | ||
| Pubmed | Molecular cloning and functional characterization of mouse Nxf family gene products. | 5.20e-05 | 10 | 38 | 2 | 15820316 | |
| Pubmed | 6.34e-05 | 197 | 38 | 4 | 31620119 | ||
| Pubmed | 7.28e-05 | 963 | 38 | 7 | 28671696 | ||
| Pubmed | 1.05e-04 | 14 | 38 | 2 | 11073998 | ||
| Pubmed | 1.20e-04 | 87 | 38 | 3 | 33711283 | ||
| Pubmed | 1.21e-04 | 15 | 38 | 2 | 18303054 | ||
| Pubmed | 1.56e-04 | 17 | 38 | 2 | 20413850 | ||
| Pubmed | 1.56e-04 | 17 | 38 | 2 | 21241894 | ||
| Pubmed | 1.92e-04 | 102 | 38 | 3 | 10231032 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 1.99e-04 | 497 | 38 | 5 | 36774506 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | 2.17e-04 | 1149 | 38 | 7 | 35446349 | |
| Pubmed | Assessment of Alzheimer's disease case-control associations using family-based methods. | 2.65e-04 | 22 | 38 | 2 | 18830724 | |
| Pubmed | 3.16e-04 | 24 | 38 | 2 | 20935629 | ||
| Pubmed | 3.16e-04 | 24 | 38 | 2 | 33705438 | ||
| Pubmed | Intermediate phenotypes identify divergent pathways to Alzheimer's disease. | 3.43e-04 | 25 | 38 | 2 | 20574532 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 4.10e-04 | 582 | 38 | 5 | 20467437 | |
| Pubmed | 4.32e-04 | 28 | 38 | 2 | 20534741 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | 5.04e-04 | 1321 | 38 | 7 | 27173435 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | 5.11e-04 | 942 | 38 | 6 | 31073040 | |
| Pubmed | Molecular architecture and assembly of the DDB1-CUL4A ubiquitin ligase machinery. | 5.65e-04 | 32 | 38 | 2 | 16964240 | |
| Pubmed | 6.00e-04 | 971 | 38 | 6 | 33306668 | ||
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 6.29e-04 | 153 | 38 | 3 | 26365490 | |
| Pubmed | 9.60e-04 | 403 | 38 | 4 | 35253629 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | 9.67e-04 | 704 | 38 | 5 | 29955894 | |
| Pubmed | 9.74e-04 | 42 | 38 | 2 | 34581821 | ||
| Pubmed | 1.06e-03 | 183 | 38 | 3 | 23956138 | ||
| Pubmed | 1.07e-03 | 44 | 38 | 2 | 26471122 | ||
| Pubmed | 1.07e-03 | 415 | 38 | 4 | 16385451 | ||
| Interaction | COPS4 interactions | 2.36e-06 | 208 | 38 | 6 | int:COPS4 | |
| Interaction | FBXW10B interactions | 1.04e-05 | 3 | 38 | 2 | int:FBXW10B | |
| Interaction | UBR4 interactions | 3.50e-05 | 334 | 38 | 6 | int:UBR4 | |
| Interaction | C19orf47 interactions | 3.55e-05 | 34 | 38 | 3 | int:C19orf47 | |
| Interaction | KIF21A interactions | 4.48e-05 | 105 | 38 | 4 | int:KIF21A | |
| Interaction | KPNA4 interactions | 6.17e-05 | 225 | 38 | 5 | int:KPNA4 | |
| Cytoband | 17p12 | 7.65e-04 | 49 | 38 | 2 | 17p12 | |
| Cytoband | 17p13.3 | 2.44e-03 | 88 | 38 | 2 | 17p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p32 | 7.35e-03 | 155 | 38 | 2 | chr1p32 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 4.17e-05 | 9 | 20 | 2 | 1230 | |
| GeneFamily | WD repeat domain containing|F-box and WD repeat domain containing | 6.36e-05 | 11 | 20 | 2 | 559 | |
| GeneFamily | WD repeat domain containing | 1.74e-04 | 262 | 20 | 4 | 362 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.85e-06 | 158 | 38 | 4 | 91d265e95156f16459924d3e4dd11c180e164eee | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Col23a1_Adamts2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.25e-05 | 168 | 38 | 4 | 3fe432267656aff81b6d92c18d1b6fc0cde73d6a | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_CD36+_endothelial_cells|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.34e-05 | 197 | 38 | 4 | 66339b5aae3952f5c484c9dcb0cfb4fbd828d4cb | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Deuterosomal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.34e-05 | 197 | 38 | 4 | 861e8df9bd74dc5e17bafdc1fb3fef546753c73a | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.48e-05 | 200 | 38 | 4 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_ALM_Hpgd|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.68e-04 | 126 | 38 | 3 | 9b04ca8a46cc30119baf6ef27711a0b2a6b4a0c9 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr-Excitatory_Neuron.Slc17a7.Nptxr-Calb1_(Superficial_layer_pyramidal_cells--Layer_2/3)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.68e-04 | 126 | 38 | 3 | 7dcc79bf35482e8e5e5a1de7279ba080edb70522 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-|Classical_Monocyte / Disease condition and Cell class | 1.81e-04 | 129 | 38 | 3 | 23b07c71142979d2178fd3a3cdeb3cde73c72c3d | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_B2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.85e-04 | 130 | 38 | 3 | 3709d17044d48b120effd8ba4104ca81c49d7e19 | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.93e-04 | 132 | 38 | 3 | 02491930097b75aaeedab9e8200711b0dc610944 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_C1ql2_Cdh13|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.11e-04 | 136 | 38 | 3 | 1f3000d5f105c87c80f8ae1dd2264bcd7f757a9c | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.30e-04 | 140 | 38 | 3 | 7cc891d676555609add6fc7880735d948a2ad801 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Col18a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.70e-04 | 148 | 38 | 3 | fc80c02b51cf55a04ce550838ee2f41d8f656f41 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.70e-04 | 148 | 38 | 3 | 223d6a640f3c34e73646a615593b9c0b4a4cbd6f | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_B2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.98e-04 | 153 | 38 | 3 | 82a96ca1912858c4311b87b3b0ba5a0a41e564b5 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.04e-04 | 154 | 38 | 3 | ec920cae12ea1d14b6c973f6e903f895f80e3c50 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.28e-04 | 158 | 38 | 3 | e5636c0b608d68bd426a2b446ac508e4512e86a4 | |
| ToppCell | COVID-CD4-CD4_Treg|COVID / Condition, Cell_class and T cell subcluster | 3.34e-04 | 159 | 38 | 3 | 037cd97c41eb2f91fd3f69bbb3ffdfd6c0158410 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 162 | 38 | 3 | 93bd29c52846c3156b8b0d2e39c552373efdfe93 | |
| ToppCell | TCGA-Uterus-Primary_Tumor-Uterine_Carcinoma-Uterine_Carcinosarcoma-3|TCGA-Uterus / Sample_Type by Project: Shred V9 | 3.59e-04 | 163 | 38 | 3 | d64dd39b077105c73e570ccef70f0e74a2c586ac | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-04 | 167 | 38 | 3 | 3dfec2fcc36caa6e394efae5e540a6fa28759977 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-04 | 167 | 38 | 3 | 95b3b5ba3414729f0460a26a0deca48de0cbe33e | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-04 | 167 | 38 | 3 | 9480739587d51e67a281778b9bddd7b5ffc3ad92 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.99e-04 | 169 | 38 | 3 | a949f547b53126a208819bade74a1ac9b2a36ea7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.99e-04 | 169 | 38 | 3 | b253a4a50c06d36228fcd5d856c57202cbac158f | |
| ToppCell | 343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.99e-04 | 169 | 38 | 3 | 195d5cd60d646ac6d40a3321b2f739917e7aef14 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-10|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.13e-04 | 171 | 38 | 3 | 74be8d3bf6b99e2d734635a8b1a7c41e8c596959 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.27e-04 | 173 | 38 | 3 | a25459b8140b0dbcb73e3b4cc1407b679229f25c | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.27e-04 | 173 | 38 | 3 | b57d14e2c2368304cb903562d06ce8228f53857c | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial-capillary_endothelial_Hpgd-CA4_high|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 4.34e-04 | 174 | 38 | 3 | cb0109661e8c9ca04d67d33f2d926f0e649bf67d | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-04 | 175 | 38 | 3 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | T_cells-Tph_and_Tfh|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.49e-04 | 176 | 38 | 3 | 56c055488e34605d32562571a2fee621b47c9441 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.56e-04 | 177 | 38 | 3 | 4943d040eee0f9dceaddc7498171281d170e271f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.56e-04 | 177 | 38 | 3 | 3f2272b577c862dba8ccfb41184054bbd0ace6f5 | |
| ToppCell | Control|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.56e-04 | 177 | 38 | 3 | b8ff6940e31b749776e81ae4f5bbd577dba9749c | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.72e-04 | 179 | 38 | 3 | ac987c9425a1b4106d1b8779a2c5461383eae2ae | |
| ToppCell | COPD-Myeloid-DC_Mature|World / Disease state, Lineage and Cell class | 4.87e-04 | 181 | 38 | 3 | 675603a401d92cf9fdcd44e211ec899fa86a0d49 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.87e-04 | 181 | 38 | 3 | 4d7793026373cbcf04b15c77f95f1025d07d4c00 | |
| ToppCell | PND07-28-samps-Endothelial-Postnatal_endothelial-capillary_endothelial_Hpgd-CA4_high|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.87e-04 | 181 | 38 | 3 | 9cd5e5c285c2b628db9d59709af053defd7c0aff | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-2|TCGA-Skin / Sample_Type by Project: Shred V9 | 4.87e-04 | 181 | 38 | 3 | 9d5b331cabc5524f0a9fd8b571e87be4c447c7d4 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.95e-04 | 182 | 38 | 3 | cc6f9d606a4f8717dc44928ceec2a257636043fd | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.95e-04 | 182 | 38 | 3 | 7af3b2029b7f55b923d5a4b764d4292f4ea48599 | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.95e-04 | 182 | 38 | 3 | ea4f6c8f600ffe9f8e0609637b3371a5ac48ca03 | |
| ToppCell | E18.5-samps-Endothelial|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.95e-04 | 182 | 38 | 3 | e2d799e6e7526176a6fe6515b8fbe4d83d3a3ea1 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-MEP|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.11e-04 | 184 | 38 | 3 | 19d61d0ab038b7e729e13a46f88b8cf31759485d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.19e-04 | 185 | 38 | 3 | 7092436b4db90289516ed130ade596e3021cffaf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.19e-04 | 185 | 38 | 3 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | Endothelial-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 5.19e-04 | 185 | 38 | 3 | ae49c61f6ecf128fe2a958b8c75c83688da75f59 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.19e-04 | 185 | 38 | 3 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 5.19e-04 | 185 | 38 | 3 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.19e-04 | 185 | 38 | 3 | a8ca7819066d5297ef6966e7f3e2c9f8a7673fdc | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 5.19e-04 | 185 | 38 | 3 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.27e-04 | 186 | 38 | 3 | 1e3ab663e4756975db6d802b2c6c054a94a79393 | |
| ToppCell | IPF-Myeloid-DC_Mature|World / Disease state, Lineage and Cell class | 5.27e-04 | 186 | 38 | 3 | d0d3953d9b199e0e792990b8551efb993393fe7e | |
| ToppCell | 343B-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.27e-04 | 186 | 38 | 3 | 9673367cb53bafb873a01ef6bda11d9f392ce648 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.36e-04 | 187 | 38 | 3 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.36e-04 | 187 | 38 | 3 | 3699d5e71d779da922920aa3160895db187bf81b | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.36e-04 | 187 | 38 | 3 | 033ba52c0c2f9978784947098fa697368ae44834 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 5.36e-04 | 187 | 38 | 3 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.36e-04 | 187 | 38 | 3 | f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.44e-04 | 188 | 38 | 3 | 73f6ec915934154f435a376cb274b058ff7c5f35 | |
| ToppCell | COPD-Myeloid-DC_Mature|COPD / Disease state, Lineage and Cell class | 5.44e-04 | 188 | 38 | 3 | de93ccb53edb8599da9e312db0e3af604c21f673 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.52e-04 | 189 | 38 | 3 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | PND07-28-samps-Endothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 5.52e-04 | 189 | 38 | 3 | eb2f8c8a90e5e9f6697a2d13274c94f40e1973e4 | |
| ToppCell | PND07-28-samps-Endothelial-Postnatal_endothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 5.52e-04 | 189 | 38 | 3 | d4a25d59d88325d3b20f4287e9b1160c82961a96 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.61e-04 | 190 | 38 | 3 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 5.61e-04 | 190 | 38 | 3 | 5130fb325f80f591b9b36beacb8072c4472304f2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.61e-04 | 190 | 38 | 3 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | COVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.61e-04 | 190 | 38 | 3 | 1caeaef78326734c1e31a0c4739190d5c5a77b9e | |
| ToppCell | PND01-03-samps-Endothelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 5.61e-04 | 190 | 38 | 3 | 1357bd4527399d7013ee33272bda7453f472999a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.69e-04 | 191 | 38 | 3 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.69e-04 | 191 | 38 | 3 | a7b18bcf27c38ad2353c239ecb309c80f3ef3359 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.69e-04 | 191 | 38 | 3 | cd854b9c426924fdc84bf7f411f6dea447143e79 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.78e-04 | 192 | 38 | 3 | c07d7b40b2aa4eb27ac85801c014a656e2fd01dc | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.78e-04 | 192 | 38 | 3 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | COPD-Myeloid-DC_Mature|Myeloid / Disease state, Lineage and Cell class | 5.78e-04 | 192 | 38 | 3 | baebd462f464e7d0e462d07a74bb5d685a9fc3b6 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.78e-04 | 192 | 38 | 3 | 04f5a2e3dd6beff027b89d66eefdd92036e041af | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor | 5.78e-04 | 192 | 38 | 3 | d21f0f577156f17c899b08871046a26b88aea011 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_activated|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 5.78e-04 | 192 | 38 | 3 | e44e37e5aeba8628556020d05e1606b28e2faa4f | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.78e-04 | 192 | 38 | 3 | 7197e401e563441ab94815f7619e032ebef9e586 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.87e-04 | 193 | 38 | 3 | 315840bc48899f3a36d57b19197509de19716e3d | |
| ToppCell | control-Myeloid-Immature_Neutrophils_2|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.87e-04 | 193 | 38 | 3 | 33349830e9eba506470ad3661fad5e5a283d20ca | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.87e-04 | 193 | 38 | 3 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.87e-04 | 193 | 38 | 3 | 3f8280ef849d95b2fcea5e6824b95a07febc96d0 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.87e-04 | 193 | 38 | 3 | c0973a2c97deb7176c2f617c8760a55f7edc9839 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.87e-04 | 193 | 38 | 3 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.87e-04 | 193 | 38 | 3 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.96e-04 | 194 | 38 | 3 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-basophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.96e-04 | 194 | 38 | 3 | 5da8873cddff582e5693b32fd3aaebc102f65fc0 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.96e-04 | 194 | 38 | 3 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | LPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.96e-04 | 194 | 38 | 3 | 58f069efdefa0366033764446b9d6ffd4a17807e | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-Aerocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.96e-04 | 194 | 38 | 3 | 54b7126b83f7482227aeaea065f504b65fa34bfe | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-B_cell-B_cell-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.96e-04 | 194 | 38 | 3 | 9a99abc65e7509e7ae8fb392f5ee4b2a83128072 | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.96e-04 | 194 | 38 | 3 | bfd92ec75facb0ba55c31e5f2e089d983b3d0169 | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.96e-04 | 194 | 38 | 3 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.05e-04 | 195 | 38 | 3 | 79a6e8e6de040ff07539e8901fc407363a50e355 | |
| ToppCell | control-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.05e-04 | 195 | 38 | 3 | bfaceb0601cf3855f38d6e1f482f01ad03ef11fe | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.05e-04 | 195 | 38 | 3 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | 343B-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 6.05e-04 | 195 | 38 | 3 | 67b05a0cd2ca9924eca81a92cc6330eecb9d963c | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.05e-04 | 195 | 38 | 3 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| Computational | Neighborhood of CHUK | 4.45e-04 | 71 | 23 | 3 | GCM_CHUK | |
| Computational | Neighborhood of MLL | 4.62e-04 | 174 | 23 | 4 | GCM_MLL | |
| Disease | Chediak-Higashi syndrome (implicated_via_orthology) | 9.17e-06 | 4 | 37 | 2 | DOID:2935 (implicated_via_orthology) | |
| Disease | Malformations of Cortical Development | 1.38e-04 | 14 | 37 | 2 | C1955869 | |
| Disease | Cortical Dysplasia | 1.38e-04 | 14 | 37 | 2 | C0431380 | |
| Disease | caudal middle frontal gyrus volume measurement | 2.31e-04 | 18 | 37 | 2 | EFO_0010290 | |
| Disease | proteinuria (implicated_via_orthology) | 6.51e-04 | 30 | 37 | 2 | DOID:576 (implicated_via_orthology) | |
| Disease | Severe Congenital Microcephaly | 6.95e-04 | 31 | 37 | 2 | C3853041 | |
| Disease | Mental Retardation, Psychosocial | 7.07e-04 | 139 | 37 | 3 | C0025363 | |
| Disease | Profound Mental Retardation | 7.07e-04 | 139 | 37 | 3 | C0020796 | |
| Disease | Mental deficiency | 7.07e-04 | 139 | 37 | 3 | C0917816 | |
| Disease | Microlissencephaly | 7.88e-04 | 33 | 37 | 2 | C1956147 | |
| Disease | IGA Glomerulonephritis | 8.37e-04 | 34 | 37 | 2 | C0017661 | |
| Disease | Hypotension | 2.03e-03 | 53 | 37 | 2 | C0020649 | |
| Disease | Acute Cerebrovascular Accidents | 2.10e-03 | 54 | 37 | 2 | C0751956 | |
| Disease | creatine kinase measurement | 2.50e-03 | 59 | 37 | 2 | EFO_0004534 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LFQELQPLYLNLHAY | 841 | P12821 | |
| LSSNLYYKYLNDLIH | 496 | O43572 | |
| LKQLNSLYLLHYFQN | 61 | Q5XX13 | |
| SLYLLHYFQNILQTT | 66 | Q5XX13 | |
| LRNAAYFLSNLKQLY | 351 | Q71F23 | |
| LSHNQGLYLYKNILA | 216 | Q7L5Y6 | |
| HNYNLIYNLSLSPQK | 506 | Q8N0U7 | |
| LQYLYLQDNHIEYLQ | 151 | Q86UN2 | |
| SLQYLYLQENSLLHL | 156 | Q86UN3 | |
| LLNYLHDFLKYLAKN | 326 | Q9UBU8 | |
| LKQLNSLYLLHYFQN | 61 | O95170 | |
| SLYLLHYFQNILQTT | 66 | O95170 | |
| LKNLVLQFLQQYYLI | 341 | Q9H4D5 | |
| AFEHLTNLNYLYLAN | 141 | Q7Z5L7 | |
| TNLNYLYLANNKLTL | 146 | Q7Z5L7 | |
| PHLYQIKQLQALANY | 341 | Q12866 | |
| ENLKSLVLHFLQQYY | 381 | Q9UBU9 | |
| LQLQILSQQKQHYNY | 326 | Q9ULH7 | |
| QLIYLNLSFNDLHYF | 346 | Q05C16 | |
| QKLEAYQHLFYLLQT | 951 | Q86VI3 | |
| ALSAIFLHNNYNYIL | 571 | Q9UPT5 | |
| NQQILLHTDFLYYLT | 236 | Q9HBI6 | |
| YHNILTNNLPNLLEY | 3111 | Q99698 | |
| ESLKQIHFLYQYSLQ | 3816 | Q14204 | |
| SNYQYLLHLNNLADR | 311 | Q92636 | |
| LALYLLHNDMNNARY | 41 | Q99627 | |
| LYKLHFQLLLLFQSY | 2831 | Q5TBA9 | |
| YLKQVLLFNNSHLTY | 391 | Q9Y2H2 | |
| QELLNLQHAYYKLNR | 421 | Q68D86 | |
| LQHAYYKLNRQYQAN | 426 | Q68D86 | |
| INNLNKSALKYYQLF | 506 | Q96EK5 | |
| FYHLNFQNNFLNILY | 61 | Q8IW52 | |
| FTLLRHLLNYAYNSN | 1376 | Q93008 | |
| VYLLNKNIAQLRYQH | 426 | Q9P2Y5 | |
| LYQLFYLANLNQDFK | 331 | Q9HAY6 | |
| HLYNFLLLKINLFNH | 31 | Q6UE05 | |
| YNMLNLLIHRKNLNY | 501 | Q6P2Q9 | |
| KNLNYLHLDYNFNLK | 511 | Q6P2Q9 | |
| SMQINHYQYLLLLFL | 816 | A0JNW5 | |
| HNLANYLFFLMYLIN | 4816 | Q15413 | |
| LYNLVHLDLSYNKLS | 331 | Q9Y2I1 | |
| NLLSLLKAYYALNAQ | 591 | P37275 | |
| QKVDAYHLQLQNLLY | 121 | Q13769 | |
| QKYRLNFYIQSLLFH | 266 | Q8WY21 |